NWAU — Fifty 1 Labs Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.06m
- $9.63m
- $5.11m
Annual income statement for Fifty 1 Labs, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2007 June 30th | R2008 June 30th | 2009 June 30th | 2010 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 6.94 | 4.51 | 5.41 | 5.11 |
| Cost of Revenue | ||||
| Gross Profit | 2.73 | 1.91 | 2.46 | 2.95 |
| Selling / General / Administrative Expenses | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 9.23 | 5.76 | 6.75 | 5.96 |
| Operating Profit | -2.29 | -1.26 | -1.34 | -0.853 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -2.29 | -2.1 | -2.23 | -1.89 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.29 | -2.1 | -2.23 | -1.89 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.29 | -2.1 | -2.23 | -1.89 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -2.29 | -2.1 | -2.23 | -1.89 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.211 | -0.214 | -0.237 | -0.202 |
| Dividends per Share |